GlassScriptPhysician profile
Michelle Y Cheng
NPI 1467871590
$5,255.07
in general payments reported to CMS, 2019-2025
19 companies · $2,795 in 2025
The $2,795 reported for 2025 was more than what 83% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $753 · 2020: $125 · 2021: $103 · 2024: $1,479 · 2025: $2,795.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,154 · Education: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,154.06 |
| Education | $119.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,603.22 | 2024-2025 | Tremfya, Stelara, Simponi Aria |
| Regeneron Healthcare Solutions, INC. | $530.91 | 2024-2025 | Dupixent |
| Genzyme Corporation | $426.28 | 2019-2025 | |
| Lilly USA, LLC | $392.50 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Galderma Laboratories, L.P. | $371.08 | 2024-2025 | Nemluvio |
| Abbvie INC. | $302.98 | 2019-2025 | |
| Incyte Corporation | $266.67 | 2024-2025 | Opzelura |
| E.R. Squibb & Sons, L.L.C. | $240.44 | 2024 | Sotyktu |
| Amgen INC. | $203.47 | 2019-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $136.04 | 2019-2025 | Cabtreo, Jublia |
| Novartis Pharmaceuticals Corporation | $135.76 | 2024-2025 | |
| Pfizer INC. | $126.14 | 2024-2025 | |
| Genentech USA, INC. | $124.56 | 2020 | |
| Sanofi-Aventis U.S. LLC | $121.71 | 2019 | |
| Janssen Scientific Affairs, LLC | $100.56 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $90.54 | 2024-2025 | Bimzelx |
| Organon LLC | $34.01 | 2025 | Hadlima |
| Sun Pharmaceutical Industries INC. | $27.85 | 2025 | |
| Leo Pharma INC. | $20.35 | 2025 | Adbry |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.